Akero Therapeutics Share Price (NASDAQ: AKRO)

$46.73

▲

-0.21

(-0.45%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Akero Therapeutics Stock chart to analyse performance

Akero Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$46.04
Today's High:$46.92
$46.73
1.48%
Downside
Day's Volatility :1.88%
Upside
0.4%
52 Weeks Low:$21.34
52 Weeks High:$58.40
$46.73
54.33%
Downside
52 Weeks Volatility :63.46%
Upside
19.98%

Akero Therapeutics Stock Returns

Period	Akero Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.88%	3.6%	0.0%
6 Months	2.61%	-7.7%	0.0%
1 Year	79.8%	-12.6%	0.0%
3 Years	269.41%	10.2%	-4.1%

Akero Therapeutics Inc Key Stats

Check Akero Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$46.94
Open	$46.95
Today's High	$46.92
Today's Low	$46.04
Market Capitalization	$3.8B
Today's Volume	$497.5K
52 Week High	$58.4
52 Week Low	$21.34
Revenue TTM	$0.0
EBITDA	$-321.5M
Earnings Per Share (EPS)	$-3.81
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-31.14%

Stock Returns calculator for Akero Therapeutics Stock including INR - Dollar returns

The Akero Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Akero Therapeutics investment value today

Current value as on today

₹1,85,084

Returns

₹85,084

(+85.08%)

Returns from Akero Therapeutics Stock

₹79,800 (+79.8%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Akero Therapeutics Stock

-36%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Akero Therapeutics Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Akero Therapeutics Inc

Name
Holdings %
Name
Holdings %
HHG PLC
8.42%
BlackRock Inc
7.82%
General Atlantic Llc
7.17%
RTW INVESTMENTS, LLC
6.85%
Vanguard Group Inc
5.66%
T. Rowe Price Associates, Inc.
5.64%

Analyst Recommendation on Akero Therapeutics Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Akero Therapeutics(by analysts ranked 0 to 5 stars)

Akero Therapeutics Share Price Target

What analysts predicted

Upside of 63.22%

Target:

$76.27

Current:

$46.73

Akero Therapeutics share price target is $76.27, a slight Upside of 63.22% compared to current price of $46.73 as per analysts' prediction.

Akero Therapeutics Stock Insights

Price Movement
In the last 1 year, AKRO stock has moved up by 71.8%

Akero Therapeutics Technicals Summary

Sell

Neutral

Buy

Akero Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Akero Therapeutics Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Akero Therapeutics Inc	-3.39%	2.61%	79.8%	269.41%	41.18%
Regeneron Pharmaceuticals, Inc.	6.48%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	2.49%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-14.45%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	13.79%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Akero Therapeutics Inc	NA	NA	NA	-3.69	-0.31	-0.2	NA	12.84
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Akero Therapeutics Inc	Buy	$3.8B	41.18%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Akero Therapeutics Inc

Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Organization	Akero Therapeutics
Employees	67
CEO	Dr. Andrew Cheng M.D., Ph.D.
Industry	Health Technology

Key Management of Akero Therapeutics Inc

Name	Title
Dr. Andrew Cheng M.D., Ph.D.	President, CEO & Director
Dr. Jonathan M. Young J.D., Ph.D.	Co-Founder, Executive VP, COO & Secretary
Mr. William R. White J.D.	Executive VP, CFO, Treasurer & Head of Corporate Development
Mr. Scott A. Gangloff	Chief Technical Officer
Ms. Catriona Yale	Executive VP & Chief Development Officer
Dr. Timothy Rolph Ph.D.	Co-Founder & Chief Scientific Officer
Mr. Thomas Ross	Senior VP & Head of Legal
Mr. John J. Schembri	Senior VP & Head of Finance
Mr. Patrick Lamy	Senior Vice President of Commercial Strategy

Important FAQs about investing in AKRO Stock from India :

What is Akero Therapeutics share price today?

Akero Therapeutics share price today is $46.73 as on August 30, 2025 at 1:29 am IST at the close of the market. Akero Therapeutics share today touched a day high of $46.92 and a low of $46.04.

What is the 52 week high and 52 week low for Akero Therapeutics share?

Akero Therapeutics share touched a 52 week high of $58.40 and a 52 week low of $21.34. Akero Therapeutics stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $46.73, lower by 19.98% versus the 52 week high.

How to invest in Akero Therapeutics Stock (AKRO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Akero Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akero Therapeutics Shares that will get you 0.0321 shares as per Akero Therapeutics share price of $46.73 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Akero Therapeutics Stock (AKRO) from India?

Indian investors can start investing in Akero Therapeutics (AKRO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Akero Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Akero Therapeutics share’s latest price of $46.73 as on August 30, 2025 at 1:29 am IST, you will get 0.2140 shares of Akero Therapeutics. Learn more about fractional shares .

What are the returns that Akero Therapeutics has given to Indian investors in the last 5 years?

Akero Therapeutics stock has given 41.18% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?